Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine

1999 ◽  
Vol 162 (2) ◽  
pp. 162-168 ◽  
Author(s):  
Masaki Sakurai ◽  
Ichiro Kanazawa
Keyword(s):  
Multiple Sclerosis ◽  
Sodium Channel ◽  
Positive Symptoms ◽  
Channel Blockers ◽  
Sodium Channel Blockers

Sodium channel blockers for neuroprotection in multiple sclerosis

2013 ◽  
Author(s):  
Chunsong Yang ◽  
Lingli Zhang ◽  
Zilong Hao ◽  
Linan Zeng ◽  
Jin Wen
Keyword(s):  
Multiple Sclerosis ◽  
Sodium Channel ◽  
Channel Blockers ◽  
Sodium Channel Blockers

Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy

2021 ◽  
Author(s):  
Emanuele Cerulli Irelli ◽  
Alessandra Morano ◽  
Martina Fanella ◽  
Biagio Orlando ◽  
Enrico M Salamone ◽  
...  
Keyword(s):  
Sodium Channel ◽  
Channel Blockers ◽  
Sodium Channel Blockers ◽  
Generalized Epilepsy

ChemInform Abstract: Substituted Biaryl Pyrazoles as Sodium Channel Blockers.

ChemInform ◽  
2010 ◽  
Vol 41 (52) ◽  
pp. no-no
Author(s):  
Sriram Tyagarajan ◽  
et al. et al.
Keyword(s):  
Sodium Channel ◽  
Channel Blockers ◽  
Sodium Channel Blockers

scholarly journals Diphenytoin, riluzole and lidocaine: Three sodium channel blockers, with different mechanisms of action, decrease hippocampal epileptiform activity

2013 ◽  
Vol 73 ◽  
pp. 48-55 ◽  
Author(s):  
Lihong Diao ◽  
Jennifer L. Hellier ◽  
Jessica Uskert-Newsom ◽  
Philip A. Williams ◽  
Kevin J. Staley ◽  
...  
Keyword(s):  
Sodium Channel ◽  
Epileptiform Activity ◽  
Mechanisms Of Action ◽  
Channel Blockers ◽  
Sodium Channel Blockers
Sign in / Sign up

Export Citation Format

Share Document